The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

lgp by the numbers
More From The Market Online
ASX Earnings concept

Week 8 CY26, Wrapped: Unusually quiet Trump amplifies ASX earnings, but Iran fears growing

It’s been an interesting two weeks, largely because we haven’t heard too much from Donald Trump lately.
The Market Online Video

Prospect Resources on ‘the copper capital of Africa’ and the tier-one mining potential in Zambia

Prospect Resources joins HotCopper to talk about why it's been looking into the underlying geology at…
The Market Online Video

Australian Gold and Copper: Maiden resource complete, growth story continues

HotCopper talks to AGC MD Glen Diemar as precious and critical metals explorer Australian Gold and…
The Market Online Video

HotCopper Highlights, Week 8: Zip unfastened; Coles in trouble, BHP’s India pivot & more

Good Afternoon and welcome to the latest edition of HotCopper Highlights where we go through the stocks and announcements you were watching this week on